List of Tables
Table 1. Global Intramuscular Injectable Suspensions Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Intramuscular Injectable Suspensions Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Intramuscular Injectable Suspensions Market Competitive Situation by Manufacturers in 2022
Table 4. Global Intramuscular Injectable Suspensions Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Intramuscular Injectable Suspensions Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Intramuscular Injectable Suspensions Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Intramuscular Injectable Suspensions Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Intramuscular Injectable Suspensions Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Intramuscular Injectable Suspensions, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Intramuscular Injectable Suspensions, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Intramuscular Injectable Suspensions, Product Type & Application
Table 12. Global Key Manufacturers of Intramuscular Injectable Suspensions, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intramuscular Injectable Suspensions by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intramuscular Injectable Suspensions as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Intramuscular Injectable Suspensions Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Intramuscular Injectable Suspensions Sales by Region (2018-2023) & (K Units)
Table 18. Global Intramuscular Injectable Suspensions Sales Market Share by Region (2018-2023)
Table 19. Global Intramuscular Injectable Suspensions Sales by Region (2024-2029) & (K Units)
Table 20. Global Intramuscular Injectable Suspensions Sales Market Share by Region (2024-2029)
Table 21. Global Intramuscular Injectable Suspensions Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Intramuscular Injectable Suspensions Revenue Market Share by Region (2018-2023)
Table 23. Global Intramuscular Injectable Suspensions Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Intramuscular Injectable Suspensions Revenue Market Share by Region (2024-2029)
Table 25. North America Intramuscular Injectable Suspensions Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Intramuscular Injectable Suspensions Sales by Country (2018-2023) & (K Units)
Table 27. North America Intramuscular Injectable Suspensions Sales by Country (2024-2029) & (K Units)
Table 28. North America Intramuscular Injectable Suspensions Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Intramuscular Injectable Suspensions Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Intramuscular Injectable Suspensions Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Intramuscular Injectable Suspensions Sales by Country (2018-2023) & (K Units)
Table 32. Europe Intramuscular Injectable Suspensions Sales by Country (2024-2029) & (K Units)
Table 33. Europe Intramuscular Injectable Suspensions Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Intramuscular Injectable Suspensions Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Intramuscular Injectable Suspensions Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Intramuscular Injectable Suspensions Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Intramuscular Injectable Suspensions Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Intramuscular Injectable Suspensions Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Intramuscular Injectable Suspensions Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Intramuscular Injectable Suspensions Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Intramuscular Injectable Suspensions Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Intramuscular Injectable Suspensions Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Intramuscular Injectable Suspensions Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Intramuscular Injectable Suspensions Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Intramuscular Injectable Suspensions Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Intramuscular Injectable Suspensions Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Intramuscular Injectable Suspensions Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Intramuscular Injectable Suspensions Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Intramuscular Injectable Suspensions Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Intramuscular Injectable Suspensions Sales (K Units) by Type (2018-2023)
Table 51. Global Intramuscular Injectable Suspensions Sales (K Units) by Type (2024-2029)
Table 52. Global Intramuscular Injectable Suspensions Sales Market Share by Type (2018-2023)
Table 53. Global Intramuscular Injectable Suspensions Sales Market Share by Type (2024-2029)
Table 54. Global Intramuscular Injectable Suspensions Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Intramuscular Injectable Suspensions Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Intramuscular Injectable Suspensions Revenue Market Share by Type (2018-2023)
Table 57. Global Intramuscular Injectable Suspensions Revenue Market Share by Type (2024-2029)
Table 58. Global Intramuscular Injectable Suspensions Price (US$/Unit) by Type (2018-2023)
Table 59. Global Intramuscular Injectable Suspensions Price (US$/Unit) by Type (2024-2029)
Table 60. Global Intramuscular Injectable Suspensions Sales (K Units) by Application (2018-2023)
Table 61. Global Intramuscular Injectable Suspensions Sales (K Units) by Application (2024-2029)
Table 62. Global Intramuscular Injectable Suspensions Sales Market Share by Application (2018-2023)
Table 63. Global Intramuscular Injectable Suspensions Sales Market Share by Application (2024-2029)
Table 64. Global Intramuscular Injectable Suspensions Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Intramuscular Injectable Suspensions Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Intramuscular Injectable Suspensions Revenue Market Share by Application (2018-2023)
Table 67. Global Intramuscular Injectable Suspensions Revenue Market Share by Application (2024-2029)
Table 68. Global Intramuscular Injectable Suspensions Price (US$/Unit) by Application (2018-2023)
Table 69. Global Intramuscular Injectable Suspensions Price (US$/Unit) by Application (2024-2029)
Table 70. Merck Sharp & Dohme Corporation Information
Table 71. Merck Sharp & Dohme Description and Business Overview
Table 72. Merck Sharp & Dohme Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Merck Sharp & Dohme Intramuscular Injectable Suspensions Product
Table 74. Merck Sharp & Dohme Recent Developments/Updates
Table 75. Novo Nordisk Corporation Information
Table 76. Novo Nordisk Description and Business Overview
Table 77. Novo Nordisk Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Novo Nordisk Intramuscular Injectable Suspensions Product
Table 79. Novo Nordisk Recent Developments/Updates
Table 80. Lilly Corporation Information
Table 81. Lilly Description and Business Overview
Table 82. Lilly Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Lilly Intramuscular Injectable Suspensions Product
Table 84. Lilly Recent Developments/Updates
Table 85. Biocon Limited Corporation Information
Table 86. Biocon Limited Description and Business Overview
Table 87. Biocon Limited Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Biocon Limited Intramuscular Injectable Suspensions Product
Table 89. Biocon Limited Recent Developments/Updates
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Pfizer Intramuscular Injectable Suspensions Product
Table 94. Pfizer Recent Developments/Updates
Table 95. BeiGene Corporation Information
Table 96. BeiGene Description and Business Overview
Table 97. BeiGene Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. BeiGene Intramuscular Injectable Suspensions Product
Table 99. BeiGene Recent Developments/Updates
Table 100. EnteraBio Corporation Information
Table 101. EnteraBio Description and Business Overview
Table 102. EnteraBio Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. EnteraBio Intramuscular Injectable Suspensions Product
Table 104. EnteraBio Recent Developments/Updates
Table 105. AbbVie Corporation Information
Table 106. AbbVie Description and Business Overview
Table 107. AbbVie Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. AbbVie Intramuscular Injectable Suspensions Product
Table 109. AbbVie Recent Developments/Updates
Table 110. Pfizer Limited Corporation Information
Table 111. Pfizer Limited Description and Business Overview
Table 112. Pfizer Limited Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Pfizer Limited Intramuscular Injectable Suspensions Product
Table 114. Pfizer Limited Recent Developments/Updates
Table 115. Teva Pharmaceuticals USA Corporation Information
Table 116. Teva Pharmaceuticals USA Description and Business Overview
Table 117. Teva Pharmaceuticals USA Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Teva Pharmaceuticals USA Intramuscular Injectable Suspensions Product
Table 119. Teva Pharmaceuticals USA Recent Developments/Updates
Table 120. Bristol-Myers Squibb Corporation Information
Table 121. Bristol-Myers Squibb Description and Business Overview
Table 122. Bristol-Myers Squibb Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Bristol-Myers Squibb Intramuscular Injectable Suspensions Product
Table 124. Bristol-Myers Squibb Recent Developments/Updates
Table 125. Cipla Corporation Information
Table 126. Cipla Description and Business Overview
Table 127. Cipla Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Cipla Intramuscular Injectable Suspensions Product
Table 129. Cipla Recent Developments/Updates
Table 130. Baxter International Corporation Information
Table 131. Baxter International Description and Business Overview
Table 132. Baxter International Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Baxter International Intramuscular Injectable Suspensions Product
Table 134. Baxter International Recent Developments/Updates
Table 135. AstraZeneca Corporation Information
Table 136. AstraZeneca Description and Business Overview
Table 137. AstraZeneca Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. AstraZeneca Intramuscular Injectable Suspensions Product
Table 139. AstraZeneca Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Intramuscular Injectable Suspensions Distributors List
Table 143. Intramuscular Injectable Suspensions Customers List
Table 144. Intramuscular Injectable Suspensions Market Trends
Table 145. Intramuscular Injectable Suspensions Market Drivers
Table 146. Intramuscular Injectable Suspensions Market Challenges
Table 147. Intramuscular Injectable Suspensions Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Intramuscular Injectable Suspensions
Figure 2. Global Intramuscular Injectable Suspensions Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Intramuscular Injectable Suspensions Market Share by Type in 2022 & 2029
Figure 4. Single-Dose Injections Product Picture
Figure 5. Multiple-Dose Injections Product Picture
Figure 6. Global Intramuscular Injectable Suspensions Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Intramuscular Injectable Suspensions Market Share by Application in 2022 & 2029
Figure 8. Hospitals Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Online Pharmacies
Figure 11. Global Intramuscular Injectable Suspensions Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Intramuscular Injectable Suspensions Market Size (2018-2029) & (US$ Million)
Figure 13. Global Intramuscular Injectable Suspensions Sales (2018-2029) & (K Units)
Figure 14. Global Intramuscular Injectable Suspensions Average Price (US$/Unit) & (2018-2029)
Figure 15. Intramuscular Injectable Suspensions Report Years Considered
Figure 16. Intramuscular Injectable Suspensions Sales Share by Manufacturers in 2022
Figure 17. Global Intramuscular Injectable Suspensions Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Intramuscular Injectable Suspensions Players: Market Share by Revenue in 2022
Figure 19. Intramuscular Injectable Suspensions Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Intramuscular Injectable Suspensions Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Intramuscular Injectable Suspensions Sales Market Share by Country (2018-2029)
Figure 22. North America Intramuscular Injectable Suspensions Revenue Market Share by Country (2018-2029)
Figure 23. United States Intramuscular Injectable Suspensions Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Intramuscular Injectable Suspensions Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Intramuscular Injectable Suspensions Sales Market Share by Country (2018-2029)
Figure 26. Europe Intramuscular Injectable Suspensions Revenue Market Share by Country (2018-2029)
Figure 27. Germany Intramuscular Injectable Suspensions Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Intramuscular Injectable Suspensions Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Intramuscular Injectable Suspensions Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Intramuscular Injectable Suspensions Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Intramuscular Injectable Suspensions Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Intramuscular Injectable Suspensions Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Intramuscular Injectable Suspensions Revenue Market Share by Region (2018-2029)
Figure 34. China Intramuscular Injectable Suspensions Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Intramuscular Injectable Suspensions Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Intramuscular Injectable Suspensions Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Intramuscular Injectable Suspensions Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Intramuscular Injectable Suspensions Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Intramuscular Injectable Suspensions Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Intramuscular Injectable Suspensions Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Intramuscular Injectable Suspensions Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Intramuscular Injectable Suspensions Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Intramuscular Injectable Suspensions Sales Market Share by Country (2018-2029)
Figure 44. Latin America Intramuscular Injectable Suspensions Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Intramuscular Injectable Suspensions Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Intramuscular Injectable Suspensions Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Intramuscular Injectable Suspensions Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Intramuscular Injectable Suspensions Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Intramuscular Injectable Suspensions Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Intramuscular Injectable Suspensions Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Intramuscular Injectable Suspensions Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Intramuscular Injectable Suspensions Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Intramuscular Injectable Suspensions by Type (2018-2029)
Figure 54. Global Revenue Market Share of Intramuscular Injectable Suspensions by Type (2018-2029)
Figure 55. Global Intramuscular Injectable Suspensions Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Intramuscular Injectable Suspensions by Application (2018-2029)
Figure 57. Global Revenue Market Share of Intramuscular Injectable Suspensions by Application (2018-2029)
Figure 58. Global Intramuscular Injectable Suspensions Price (US$/Unit) by Application (2018-2029)
Figure 59. Intramuscular Injectable Suspensions Value Chain
Figure 60. Intramuscular Injectable Suspensions Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
